Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Invested Capital (2016 - 2018)

China Pharma Holdings (CPHI) has disclosed Return on Invested Capital for 8 consecutive years, with 0.08% as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Return on Invested Capital rose 29.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Dec 2018, up 29.0%, and an annual FY2018 reading of 0.07%, up 29.0% over the prior year.
  • Return on Invested Capital was 0.08% for Q4 2018 at China Pharma Holdings, up from 0.41% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.03% in Q2 2017 and bottomed at 0.44% in Q1 2015.
  • Average Return on Invested Capital over 5 years is 0.25%, with a median of 0.32% recorded in 2015.
  • Peak annual rise in Return on Invested Capital hit 29bps in 2018, while the deepest fall reached -37bps in 2018.
  • Year by year, Return on Invested Capital stood at 0.37% in 2014, then surged by 50bps to 0.18% in 2015, then skyrocketed by 80bps to 0.04% in 2016, then crashed by -920bps to 0.37% in 2017, then soared by 79bps to 0.08% in 2018.
  • Business Quant data shows Return on Invested Capital for CPHI at 0.08% in Q4 2018, 0.41% in Q3 2018, and 0.38% in Q2 2018.